tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Ventricular Dysfunction, Left D018487 33 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Neuritis D009443 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Hepatitis C D006526 7 associated lipids
Lichen Planus D008010 3 associated lipids
Sclerosis D012598 5 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Insulin Resistance D007333 99 associated lipids
Liver Failure, Acute D017114 11 associated lipids
Diabetes Complications D048909 4 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Coronary Stenosis D023921 6 associated lipids
Dehydration D003681 11 associated lipids
Hemophilia A D006467 10 associated lipids
Encephalitis D004660 15 associated lipids
Dyslipidemias D050171 7 associated lipids
Fatigue D005221 10 associated lipids
Meningoencephalitis D008590 4 associated lipids
Gynecomastia D006177 6 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Myxedema D009230 2 associated lipids
Pregnancy Complications D011248 19 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Stomatitis D013280 14 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Lung Diseases, Interstitial D017563 5 associated lipids
Weight Loss D015431 56 associated lipids
Tinea D014005 5 associated lipids
Critical Illness D016638 13 associated lipids
Endotoxemia D019446 27 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Memory Disorders D008569 33 associated lipids
Glucose Intolerance D018149 13 associated lipids
Dry Eye Syndromes D015352 10 associated lipids
Thinness D013851 11 associated lipids
Opportunistic Infections D009894 8 associated lipids
Eczema D004485 4 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Rhabdomyolysis D012206 9 associated lipids
Lupus Nephritis D008181 8 associated lipids
Telangiectasis D013684 2 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Nakagawa K et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. 2015 Am. J. Reprod. Immunol. pmid:25394810
Farnik H et al. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation. 2015 Liver Int. pmid:24649882
Cantaluppi V et al. Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors. 2015 PLoS ONE pmid:26125566
Fukahori H et al. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation. 2015 Int. Immunopharmacol. pmid:26122135
Langone A et al. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study. 2015 Clin Transplant pmid:26113208
Eidens M et al. Development and validation of a rapid and reliable real-time PCR method for CYP3A5 genotyping. 2015 Clin. Lab. pmid:25975003
Castaneda J and Matzuk MM DEVELOPMENTAL BIOLOGY. Toward a rapid and reversible male pill. 2015 Science pmid:26494747
Safa K et al. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report. 2015 Clin. Nephrol. pmid:24495904
Staatz CE and Tett SE Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients. 2015 Clin Pharmacokinet pmid:26038096
Migita K et al. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus. 2015 Arthritis Res. Ther. pmid:26036592
Miyata H et al. Sperm calcineurin inhibition prevents mouse fertility with implications for male contraceptive. 2015 Science pmid:26429887
Wiseman AC Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know. 2015 Clin J Am Soc Nephrol pmid:25979977
Tanriover B et al. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. 2015 Clin J Am Soc Nephrol pmid:25979971
Meyer C et al. Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques. 2015 Clin. Exp. Immunol. pmid:25902927
Sassi MB et al. Involvement of CYP 3A5 In the Interaction Between Tacrolimus and Nicardipine: A Case Report. 2015 Curr Drug Saf pmid:25968921
Wang CY et al. Analysis of tacrolimus blood concentrations in renal transplant patients. 2015 Genet. Mol. Res. pmid:25966149
Bedi M and Taylor AL Recalcitrant Hailey-Hailey disease responds to oral tacrolimus and botulinum toxin type A. 2015 Cutis pmid:26761940
Nagaya M et al. A new system to evaluate the influence of immunosuppressive drugs on pancreatic islets using epigenetic analysis in a 3-dimensional culture. 2015 Pancreas pmid:25906448
Wang M et al. Enteric polymer based on pH-responsive aliphatic polycarbonate functionalized with vitamin E to facilitate oral delivery of tacrolimus. 2015 Biomacromolecules pmid:25714622
Gallon L et al. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. 2015 Transplantation pmid:25905982
Gajzlerska W et al. Use of three-carbon chain compounds as biosynthesis precursors to enhance tacrolimus production in Streptomyces tsukubaensis. 2015 N Biotechnol pmid:25152525
Yu Z et al. IL-15 is decreased upon CsA and FK506 treatment of acute rejection following heart transplantation in mice. 2015 Mol Med Rep pmid:25333459
Selk A A Survey of Experts Regarding the Treatment of Adult Vulvar Lichen Sclerosus. 2015 J Low Genit Tract Dis pmid:25853633
Hurst AL et al. Supra-therapeutic tacrolimus concentrations associated with concomitant nicardipine in pediatric liver transplant recipients. 2015 Pediatr Transplant pmid:25850753
Tajdaran K et al. A novel polymeric drug delivery system for localized and sustained release of tacrolimus (FK506). 2015 Biotechnol. Bioeng. pmid:25850693
Jacobo-Cabral CO et al. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. 2015 Br J Clin Pharmacol pmid:25846845
Bowman LJ et al. Tacrolimus-Induced Cardiomyopathy in an Adult Renal Transplant Recipient. 2015 Pharmacotherapy pmid:26616582
Miguel-Gómez L et al. [Peristomal pyoderma gangrenosum associated with colon cancer]. 2015 Med Clin (Barc) pmid:25659860
Romanowski M et al. Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus. 2015 Pharmacogenomics pmid:26282401
Girdlestone J et al. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs. 2015 Cytotherapy pmid:26276002
Dedinská I et al. Waist circumference as an independent risk factor for NODAT. 2015 Ann. Transplant. pmid:25791039
Suzuki N et al. In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain. 2015 PLoS ONE pmid:25790231
Ross A and Kirsner RS JID VisualDx Quiz: April 2015. 2015 J. Invest. Dermatol. pmid:25785952
Heneberg P et al. Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro. 2015 PLoS ONE pmid:26562153
Yang CJ et al. Differential Large-Amplitude Breathing Motions in the Interface of FKBP12-Drug Complexes. 2015 Biochemistry pmid:26561008
Fan J et al. Donor IL-18 rs5744247 polymorphism as a new biomarker of tacrolimus elimination in Chinese liver transplant patients during the early post-transplantation period: results from two cohort studies. 2015 Pharmacogenomics pmid:25712187
Duong SQ et al. Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients. 2015 Pediatr Transplant pmid:26497983
Jóźwiak-Bębenista M et al. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation. 2015 Pharmacol Rep pmid:25712659
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Pucci N et al. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study. 2015 Pediatr Allergy Immunol pmid:25712437
Katayama K et al. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice. 2015 Mod Rheumatol pmid:24983407
Kim KW et al. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. 2015 Immunology pmid:24974886
Yessayan L et al. Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation. 2015 Transplant. Proc. pmid:26707323
Yoon NY et al. Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model. 2015 Arch. Dermatol. Res. pmid:25786383
Tanaka M et al. Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders. 2015 Mult. Scler. pmid:25662352
Van der Perren A et al. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease. 2015 Neurobiol. Aging pmid:25660193
Wu SC et al. Identification of Circulating miRNAs in a Mouse Model of Nerve Allograft Transplantation under FK506 Immunosuppression by Illumina Small RNA Deep Sequencing. 2015 Dis. Markers pmid:26435568
Okechuku G et al. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine. 2015 Pediatr Transplant pmid:25661468
Kume K et al. Screening for a gene deletion mutant whose temperature sensitivity is suppressed by FK506 in budding yeast and its application for a positive screening for drugs inhibiting calcineurin. 2015 Biosci. Biotechnol. Biochem. pmid:25614218
Garnock-Jones KP Tacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipients. 2015 Drugs pmid:25613762
Li CJ and Li L Tacrolimus in preventing transplant rejection in Chinese patients--optimizing use. 2015 Drug Des Devel Ther pmid:25609922
Uemoto S et al. Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients. 2015 Clin. Exp. Immunol. pmid:25603847
Dave CN et al. Innovative use of intravesical tacrolimus for hemorrhagic radiation cystitis. 2015 Int Urol Nephrol pmid:26347076
Wu J et al. MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. 2015 J. Clin. Invest. pmid:26436650
Overk CR et al. Differential calcium alterations in animal models of neurodegenerative disease: Reversal by FK506. 2015 Neuroscience pmid:26341908
de Jonge H et al. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. 2015 Br J Clin Pharmacol pmid:26114223
Kallscheuer N et al. Single-Domain Peptidyl-Prolyl cis/trans Isomerase FkpA from Corynebacterium glutamicum Improves the Biomass Yield at Increased Growth Temperatures. 2015 Appl. Environ. Microbiol. pmid:26341203
Schnitzbauer AA et al. Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation. 2015 Ann. Transplant. pmid:25553853
Aruch DB and Renteria A Simultaneous PRES and TMA secondary to tacrolimus after allogeneic bone marrow transplant. 2015 Blood pmid:26287041
Pagliarello C et al. Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison. 2015 Eur J Dermatol pmid:25786341
Gong N et al. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients. 2015 Cell. Immunol. pmid:26205091
Chamani G et al. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. 2015 Int. J. Dermatol. pmid:26204904
Muduma G et al. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK. 2015 J Med Econ pmid:26201252
Mizuno K et al. Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model. 2015 J. Dermatol. Sci. pmid:26198442
Rathi M et al. Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. 2015 Transplant. Proc. pmid:26036543
Mohsin N et al. Pharmacokinetics of mycophenolate mofetil in Omani patients on cyclosporine or tacrolimus. 2015 Transplant. Proc. pmid:26036534
Rivinius R et al. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. 2015 Drug Des Devel Ther pmid:25552900
Kabrine M and Laraba-Djebari F Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation. 2014 Jan-Mar Int J Immunopathol Pharmacol pmid:24674680
Wang C and Lin A Efficacy of topical calcineurin inhibitors in psoriasis. 2014 Jan-Feb J Cutan Med Surg pmid:24377467
Feito-Rodríguez M et al. Bacterial vaginosis in the context of lichen sclerosus in a prepubertal girl. 2014 Jan-Feb Pediatr Dermatol pmid:24125016
Veisa G et al. The importance of renal biopsy in the management of renal transplantation. 2014 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:25076703
Mo D et al. In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei. 2014 Mycopathologia pmid:25052248
Silva HT et al. Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients. 2014 Transplantation pmid:24521771
Alloway RR et al. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients. 2014 Liver Transpl. pmid:24493215
Tsuchimoto A et al. Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients. 2014 PLoS ONE pmid:25329716
Danby SG et al. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis. 2014 Br. J. Dermatol. pmid:24328907
Tavira B et al. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients. 2014 Gene pmid:24445060
Kato H et al. Significant improvement of Takayasu arteritis after cord blood transplantation in a patient with myelodysplastic syndrome. 2014 Bone Marrow Transplant. pmid:24317130
Barreiro C and Martínez-Castro M Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506). 2014 Appl. Microbiol. Biotechnol. pmid:24272367
Budde K et al. Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. 2014 Am. J. Transplant. pmid:25278376
Xu W et al. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time. 2014 Int J Pharm pmid:24172796
Gomez-Moyano E et al. Periorbital granuloma annulare successfully treated with tacrolimus 0.1% ointment. 2014 Int. J. Dermatol. pmid:23432464
Posadas Salas MA and Srinivas TR Update on the clinical utility of once-daily tacrolimus in the management of transplantation. 2014 Drug Des Devel Ther pmid:25210441
Nasu R et al. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases. 2014 Ann. Hematol. pmid:24590535
Taber DJ et al. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. 2014 Am. J. Nephrol. pmid:24969370
Keniya MV et al. Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5. 2014 Mol. Pharm. pmid:25115303
Ko SF et al. Therapeutic potential of tacrolimus on acute myocardial infarction in minipigs: analysis with serial cardiac magnetic resonance and changes at histological and protein levels. 2014 Biomed Res Int pmid:25114905
Oh CK et al. Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation. 2014 Yonsei Med. J. pmid:25048494
Piao SG et al. Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions. 2014 Transplantation pmid:24825522
Gujadhur A et al. CMV sinusitis in a HIV-negative renal transplant recipient. 2014 Transplantation pmid:24827770
Navas-López VM et al. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis. 2014 J Crohns Colitis pmid:23582736
Ohe M et al. Successful treatment with tacrolimus of refractory adult-onset Still's disease. 2014 Korean J. Intern. Med. pmid:24648814
Toniutto P et al. Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated. 2014 Int J Surg pmid:25219480
Langone A et al. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation. 2014 Clin Transplant pmid:24893821
Tümgör G et al. A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. 2014 Turk J Gastroenterol pmid:25599790
Korbel L et al. Clinically relevant pharmacogenomic testing in pediatric practice. 2014 Clin Pediatr (Phila) pmid:24803633
Chung BH et al. Decrease of immature B cell and interleukin-10 during early-post-transplant period in renal transplant recipients under tacrolimus based immunosuppression. 2014 Transpl. Immunol. pmid:24709525
Al-Kadhimi Z et al. High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. 2014 Biol. Blood Marrow Transplant. pmid:24709007
Hässig A et al. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor. 2014 Transpl Infect Dis pmid:24134704
Manousou P et al. Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. 2014 Gut pmid:24131637